Clinical Trial Update: Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine

View source ↗

Summary

A completed clinical trial evaluating the persistence of anti-Leptospira antibodies in subjects vaccinated with Spirolept® Vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptospirosis

Drugs mentioned

• Spirolept® Vaccine

Snippet

Sponsor: Imaxio | Conditions: Leptospirosis | Status: COMPLETED